Phoenix Financial’s Labcorp LH Stock Holding History

Phoenix Financial’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Buy	896 +85	+10%	+$22.3K	﹤0.01%	464
2026 Q1	$216K	Buy	+811	New	+$220K	﹤0.01%	449

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Phoenix Financial's LH Position: Q2 2026 in Review

Phoenix Financial increased its Labcorp (LH) stake by 10% in Q2 2026, buying an estimated $22.3K and bringing the position to 896 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Phoenix Financial first reported a position in LH in Q1 2026 and has held it in 2 quarters since. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Phoenix Financial held 896 shares of Labcorp worth $251K as of Q2 2026.
Phoenix Financial bought 85 Labcorp shares in Q2 2026, an estimated $22.3K.
Labcorp made up ﹤0.01% of Phoenix Financial's portfolio in Q2 2026, its #464 holding.
Phoenix Financial first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.